Canada Markets open in 5 hrs 17 mins

BioVaxys Technology Corp. (BVAXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.08000.0000 (0.00%)
At close: 03:34PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0800
Open0.0700
BidN/A x N/A
AskN/A x N/A
Day's Range0.0800 - 0.0800
52 Week Range0.0616 - 0.3800
Volume12,004
Avg. Volume55,789
Market Cap7.27M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0540
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Baystreet

    Stocks in play: BioVaxys Technology Corp

    Announces that it has closed the final tranche of its previously announced non-brokered private placement. ...

  • CNW Group

    BIOVAXYS CLOSES FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENT

    BioVaxys Technology Corp. (CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has closed the final tranche ("Final Tranche") of its previously announced non-brokered private placement (the "Private Placement"). Pursuant to the Final Tranche of the Private Placement, the Company has issued 1,350,000 units ("Units") at a price of $0.10 per Unit for gross proceeds of $135,000. Including the first tranche of the Private Placement which completed on August

  • CNW Group

    BioVaxys Announces New Chief Financial Officer

    BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that Mr. Craig Loverock has joined the Company as Chief Financial Officer. Mr. Loverock is replacing Mr. Lachlan McLeod, who has been the acting CFO following the transition from Lions Bay Mining Inc. to BioVaxys in October 2020. Mr. McLeod will be resuming his full-time duties with Fehr & Associates CPA.